Data gathered: June 23
AI Stock Analysis - PROCEPT BioRobotics (PRCT)
Analysis generated October 27, 2024. Powered by Chat GPT.
PROCEPT BioRobotics is a pioneering company in the field of surgical robotics. The company specializes in the development of innovative solutions for urological conditions, particularly through its flagship product, the Aquablation therapy. This robot-assisted procedure revolutionizes the treatment of benign prostatic hyperplasia (BPH), providing a minimally invasive option for patients. PROCEPT's unique technology has garnered significant attention and adoption in the medical community, positioning the company as a leader in its niche market.
Stock Alerts - PROCEPT BioRobotics (PRCT)
 |
PROCEPT BioRobotics | June 13 Insider Alert: Desai Antal Rohit is continuing selling shares |
|
PROCEPT BioRobotics | June 7 Insider Alert: Shiblaq Hisham is selling shares |
|
PROCEPT BioRobotics | June 6 Insider Alert: Desai Antal Rohit is selling shares |
|
PROCEPT BioRobotics | June 5 Price is up by 7.5% in the last 24h. |
Download our app to get future alerts delivered in real-time.
Alternative Data for PROCEPT BioRobotics
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 57 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 22,000 | Sign up | Sign up | Sign up |
| Google Trends | 9 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 889 | Sign up | Sign up | Sign up |
| Twitter Followers | 1,397 | Sign up | Sign up | Sign up |
| Twitter Mentions | 8 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Linkedin Employees | 717 | Sign up | Sign up | Sign up |
About PROCEPT BioRobotics
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH).
| Price | $58.74 |
| Target Price | Sign up |
| Volume | 441,310 |
| Market Cap | $3.33B |
| Year Range | $48.82 - $99.45 |
| Dividend Yield | 0% |
| Analyst Rating | 78% buy |
| Industry | Medical Devices |
In the news
 |
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Shares Purchased by Avior Wealth Management LLCJune 23 - ETF Daily News |
|
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Shares Bought by Blue Trust Inc.June 23 - ETF Daily News |
|
Rhumbline Advisers Purchases 3,077 Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT)June 15 - ETF Daily News |
|
PROCEPT BioRobotics Co. (NASDAQ:PRCT) Receives $90.00 Average Target Price from AnalystsJune 4 - ETF Daily News |
|
Wall Street Zen Upgrades PROCEPT BioRobotics (NASDAQ:PRCT) to “Hold”May 25 - ETF Daily News |
 |
PROCEPT BioRobotics: A 'Razor And Razor Blade' Business ModelMay 18 - SeekingAlpha |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '25 | 69M | 25M | 44M | -25M | -22M | -0.450 |
| Q4 '24 | 68M | 25M | 44M | -19M | -16M | -0.350 |
| Q3 '24 | 58M | 21M | 37M | -21M | -19M | -0.400 |
| Q2 '24 | 53M | 23M | 30M | -26M | -23M | -0.500 |
| Q1 '24 | 45M | 20M | 25M | -26M | -24M | -0.510 |
Insider Transactions View All
| Desai Antal Rohit filed to sell 14,363 shares at $62.3. June 12 '25 |
| Desai Antal Rohit filed to sell 19,412 shares at $61.3. June 12 '25 |
| Desai Antal Rohit filed to sell 39,363 shares at $64.3. June 12 '25 |
| Desai Antal Rohit filed to sell 56,575 shares at $62.6. June 12 '25 |
| Desai Antal Rohit filed to sell 45,080 shares at $63.5. June 12 '25 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Boston ScientificBSX |
$102.36 1% | 53 |
 |
Edwards LifesciencesEW |
$75.32 2% | 29 |
 |
Intuitive SurgicalISRG |
$515.09 1.1% | 68 |
 |
MedtronicMDT |
$85.96 0.4% | 56 |
 |
StrykerSYK |
$379.16 1% | 45 |
Read more about PROCEPT BioRobotics (PRCT) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews & linkedin employees.
What is the Market Cap of PROCEPT BioRobotics?
The Market Cap of PROCEPT BioRobotics is $3.33B.
What is the current stock price of PROCEPT BioRobotics?
Currently, the price of one share of PROCEPT BioRobotics stock is $58.74.
How can I analyze the PRCT stock price chart for investment decisions?
The PRCT stock price chart above provides a comprehensive visual representation of PROCEPT BioRobotics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling PROCEPT BioRobotics shares. Our platform offers an up-to-date PRCT stock price chart, along with technical data analysis and alternative data insights.
Does PRCT offer dividends to its shareholders?
As of our latest update, PROCEPT BioRobotics (PRCT) does not offer dividends to its shareholders. Investors interested in PROCEPT BioRobotics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of PROCEPT BioRobotics?
Some of the similar stocks of PROCEPT BioRobotics are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
.